Wählen Sie hier durch Anklicken den Anfangsbuchstaben ihres
 gesuchten Antigens / Epitops oder der zellulären Struktur:

A, B, C+ D, E, F, G, H, I, K, L, M, N, O, P+R,  S+T,  U+V, Literatur

 

Literatur zur Antikörperliste

  1. Ansai S, Hashimoto H, Aoki T et al. (1993)
    A histochemical and immunohistochemical study of extra-ocular sebaceous carcinoma. 
    Histopathology 22, 127-33
  2. Arber DA, Weiss LM (1993)
    CD15. A review.
    Applied Immunohistochemistry 1, 17-30
  3. Arber DA, Weiss LM (1993)
    CD43. A review.
    Applied Immunohistochemistry 1, 88-96
  4. Arber DA, Weiss LM (1995)
    CD5. A review.
    Applied Immunohistochemistry 3, 1-22
  5. Arber DA, Weiss LM (1995)
    CD57. A review.
    Applied Immunohistochemistry 3, 137-52
  6. Arber DA, Weiss LM (1997)
    CD10. A review.
    Applied Immunohistochemistry 5, 125-140

    zum Anfang der Seite
  7. Bacchi CE, Bonetti F, Pea M et al. (1996)
    HMB45. A review.
    Applied Immunohistochemistry 4, 73-85
  8. Battocchio S, Stas M, Maes A et al. (1999)
    CD30 expression in melanocytic lesions.
    Applied Immunohistochemistry & Molecular Morphology 7, 169-72
  9. Brandtzaeg P, Dale I, Gabrielsen TO (1992)
    The leukozyte protein L1 (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological function.
    Histopathology 21, 191-6
  10. Breiteneder-Geleff S, Soleiman A, Kowalski H et al. (1999)
    Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Podoplanin as a specific marker for lymphatic endothelium.
    Am J Pathol 154, 385-94
  11. Cerroni L, Kerl H, Gatter K (1998)
    An illustrated guide to skin lymphoma.
    Blackwell, Oxford
  12. Chan JKC (1997)
    CD56-positive putative natural killer (NK) cell lymphomas: nasal, nasal-type, blastoid, and leukemic forms.
    Advances in Anatomic Pathology 4, 163-172.

    zum Anfang der Seite
  13. Chan JKC (1998)
    Anaplastic large cell lymphoma: redefining its morphologic spectrum and importance of recognition of the ALK-positive subset.
    Advances in Anatomic Pathology 5, 281-313
  14. Chan JKC (1999)
    Peripheral T-cell lymphoma and NK-cell neoplasms: an integrated approach to diagnosis.
    Mod Pathol 12, 177-99.
  15. Chan JKC, Suster S, Wenig B et al. (1997)
    Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites.
    Am J Surg Pathol 21, 226-234
  16. Chang KL, Arber DA, Weiss LM (1993)
    CD30. A review.
    Applied Immunohistochemistry 1, 244-55
  17. Chang KL, Arber DA, Weiss LM (1996)
    CD20. A review.
    Applied Immunohistochemistry 4, 1-15
  18. Chilosi M, Pizzolo G (1995)
    Review of terminal deoxynucleotidyl transferase. Biological aspects, methods of detection, and selected diagnostic applications.
    Applied Immunohistochemistry 3, 209-221

    zum Anfang der Seite
  19. Chimenti S, Fink-Puches R, Peris K, Pescarmona E, Pütz B, Kerl H, Cerroni L (1999)
    Cutaneous involvement in lymphoblastic lymphoma.
    J Cutan Pathol 26, 379-85
  20. Demirkesen C, Hoede N, Moll R (1995)
    Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins.
    J Cutan Pathol 22, 518-535
  21. De Potter CR (1994)
    The neu-oncogene: more than a prognostic indicator?
    Hum Pathol 25, 1264-8
  22. Doglioni C, Die Tos A, Laurino L et al. (1996)
    Calretinin : a novel immunocytochemical marker for mesothelioma.
    Am J Surg Pathol 20, 1037-46
  23. Dhir RK, Nalesnik MA, Demetris AJ et al. (1995)
    Latent membrane protein expression in posttransplant lymphoproliferative disease.
    Applied Immunohistochemistry 3, 123-6
  24. Fogt F, Capodieci P, Loda M (1995)
    Assessment of perineural invasion by GLUT1 immunohistochemistry.
    Appl Immunohistochem 3, 194-7

    zum Anfang der Seite
  25. Folpe AL, Patterson K, Gown AM (1997)
    Antineuroblastoma antibody NB-84 also identifies a significant subset of other small blue round cell tumors.
    Applied Immunohistochemistry 5, 239-45
  26. Foschini MP, Eusebi V (1995)
    The spectrum of endocrine tumours of skin.
    Current Diagnostic Pathology 2, 2-9

  27. Gloghini A, De Paoli P, Gaidano G, Franceschi S, Carbone A (1995)
    High frequency of CD45RO expression in AIDS-related B-cell non-Hodgkin’s lymphomas. 
    Am J Clin Pathol 104, 680-8

  28. Goldblum JR, Hart WR (1998)
    Perianal Paget’s disease. A histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma.
    Am J Surg Pathol 22, 170-9
  29. Hanna W, Kahn HJ, Trudeau M (1999)
    Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside.
    Mod Pathol 12: 827-34
  30. Harnden P, Mahmood N, Southgate J (1999)
    Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. 
    Lancet 353, 974-7

    zum Anfang der Seite
  31. Heatley MK (1996) 
    Cytokeratins and cytokeratin staining in diagnostic histopathology.
    Histopathology 28, 479-83
  32. Kahn HJ, Thorner PS (1992)
    »False immunohistochemical positivity» associated with mycobacterial infection in acquired immune deficiency syndrome.
    Am J Surg Pathol 16, 1126-9
  33. Kohler S, Rouse RV, Smoller BR (1998)
    The differential diagnosis of pagetoid cells in the epidermis.
    Mod Pathol 11, 79-92
  34. Kutzner H (1993)
    Expression of human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue.
    J Am Acad Dermatol 28, 613-7
  35. Kutzner H, Argenyi ZB, Requena L, Rütten A, Hügel H (1998)
    A new application of BCG antibody for rapid screening of various tissue microorganisms.
    J Am Acad Dermatol 38, 56-60
  36. Leong ASY, Cooper K, Leong FJWM (1999)
    Manual of diagnostic antibodies for immunohistology.
    London, Greenwich Medical Media

    zum Anfang der Seite
  37. Li WV, Kapadia SB, Sonmez-Alpan E et al. (1996)
    Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
    Mod Pathol 9, 982-8
  38. Liu CC, Young LHY, Young JDE (1996)
    Lymphocyte-mediate cytolysis and disease.
    N Engl J Med 22, 1651-9
  39. Lloyd RV (1996)
    Overview of neurocrine cells and tumors.
    Endocrine Pathol 7, 323-8
  40. Longacre T, Rouse RV (1994)
    CD31. A new marker for vascular neoplasia.
    Advances in Anatomic Pathology 1, 16-20
  41. Lundquist K, Kohler S, Rouse RV (1999)
    Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells.
    Am J Surg Pathol 23, 212-9
  42. MacLennan KA, Diebold J (1998)
    Anaplastic large cell lymphoma.
    Current Diagnostic Pathology 5, 165-73

    zum Anfang der Seite
  43. McHugh M, Miettinen M (1994)
    KP1 (CD68). Its limited specificity for histiocytic tumors. 
    Applied Immunohistochemistry 2, 186-190
  44. Metze D, Soyer HP, Zelger B et al. (1996)
    Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland marker.
    J Am Acad Dermatol 34, 735-44
  45. Miettinen M (1995)
    Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas.
    Mod Pathol 8, 384-8
  46. Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, Fetsch JF (1999)
    Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis.
    Hum Pathol 30, 934-42
  47. Miettinen M, Fetsch JF (1997)
    Keratin 7 reactivity in endothelial cells: a potential pitfall in diagnostic immunohistochemistry.
    Applied Immunohistochemistry 5, 229-233
  48. Moll R (1998)
    Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors.
    In: Herrmann, Harris (eds.) 
    Subcellular Biochemistry 31, 205-262. New York, Plenum Press

    zum Anfang der Seite
  49. Moll R, Franke WW, Schiller DL et al. (1982)
    The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.
    Cell 31, 11-24
  50. Pezzella F, Gatter K (1995)
    What is the value of bcl-2 protein detection for histopathologists?
    Histopathology 26, 89-93
  51. Polski JM, Janney CG (1999)
    Ber-H2 (CD30) immunohistochemical staining in malignant melanoma.
    Mod Pathol 12, 903-6
  52. Renshaw AA (1995) O13 (CD99) in spindle cell tumors, reactivities with hemangiopericytoma, solitary fibrous tumor, synovial sarcoma, and meningioma but rarely with sarcomatoid mesothelioma. 
    Appl Immunohistochem 3, 250-6
  53. Robertson PB, Neiman RS, Worapongpaiboon S, John K, Orazi A (1997)
    O13 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Mod Pathol 10, 277-282
  54. Saeger W, Röcken CH (1998)
    Amyloid: Mikroskopischer Nachweis, Klassifikation und klinischer Bezug.
    Pathologe 19, 345-54

    zum Anfang der Seite
  55. Sander CA, Flaig MJ (1999)
    Morphologic spectrum of cutaneous B-cell lymphomas.
    Dermatologic Clinics 17, 593-9
  56. Selby L, Nance KV, Park HK (1992)
    CEA immunoreactivity in metastatic malignant melanoma.
    Mod Pathol 5, 415-9
  57. Shah IA, Netto D, Schlageter MO et al. (1993)
    Neurofilament immunoreactivity in Merkel-cell tumors: a differentiating feature from small-cell carcinoma.
    Mod Pathol 6, 3-9
  58. Shipley WR, Hammer RD, Lennington WJ, Macon WR (1997) Paraffin immunohistochemical detection of CD56, a usefull marker for neural cell adhesion molecule (NCAM), in normal and neoplastic fixed tissues. Applied Immunohistochemistry 5, 87-93
  59. Smack DP, Korge BP, James WD et al. (1994)
    Keratin and keratinization.
    J Am Acad Dermatol 30, 85-102
  60. Templeton SF (1995)
    Evaluation for expression of factor XIIIa and CD34 is of practical value in the diagnosis of selected lesions of dermatofibroma and dermatofibrosarcoma protuberans.
    Advances in Anatomic Pathology 4, 270-274

    zum Anfang der Seite
  61. Thomas G, Kay EW, Nyham B et al. (1997)
    VS38c shows lack of specificity as a marker of plasma cells.
    Applied Immunohistochemistry 5, 185-188
  62. Tomaszewski MM, Lupton GP (1998)
    Unusual expression of S-100 protein in histiocytic neoplasms.
    J Cutan Pathol 25, 129-135
  63. van de Rijn M, Rouse RV (1994)
    CD34. A review.
    Applied Immunohistochemistry 2, 71-80
  64. Vartanian RK, Sudilovsky D, Weidner N (1996)
    Immunostaining of monoclonal antibody O13 (anti-MIC2 gene product (CD99)) in lymphomas.
    Appl Immunohistochem 4, 43-55
  65. Wang AR, May D, Bourne P, Scott G (1999)
    PGP9.5 – A marker for cellular neurothekeoma.
    Am J Surg Pathol 23, 1401-7
  66. Wang NP, Marx J, McNutt MA et al. (1995)
    Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.
    Am J Pathol 147, 1799-810

    zum Anfang der Seite
  67. Weiss LM, Arber DA, Chang KL (1993)
    CD45. A review.
    Applied Immunohistochemistry 1, 166-81
  68. Weiss LM, Arber DA, Chang KL (1994)
    CD68. A review.
    Applied Immunohistochemistry 2, 2-8
  69. Willemze R, Beljaards RC, Meijer CJL (1994)
    Classification of primary cutaneous T-cell lymphomas.
    Histopathology 24, 405-15.
  70. Willemze R, Meijer CJLM (1998)
    Classification of cutaneous lymphomas: crosstalk between pathologist and clinician.
    Current Diagnostic Pathology 5, 23-33
  71. Wong KF, Chan JKC (1995)
    Antimyeloperoxidase: antibody of choice for labeling of myeloid cells including diagnosis of granulocytic sarcoma.
    Advances in Anatomic Pathology 2, 65-8
  72. Zeng Z, Melamed J, Symmans PJ et al. (1999)
    Benign proliferative nipple duct lesions frequently contain CAM 5.2 and anti-cytokeratin 7 immunoreactive cells in the overlying epidermis.
    Am J Surg Pathol 23, 1349-55

zurück zum INDEX

zum Anfang der Seite

Zurück Home Nach oben

© 1998-2010     Dermatopathologie Friedrichshafen, Bodensee, Siemensstraße 6/1, 88048 Friedrichshafen, Germany,
                         Tel. 07541/6044-0, Fax 07541/6044-10, email: dermpath@dermpath.de

                         webmistress  j.schroeder@dermpath.de             letzte Aktualisierung 18.01.2008 18:30